340 related articles for article (PubMed ID: 30305849)
1. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.
Stolte B; Totzeck A; Kizina K; Bolz S; Pietruck L; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
Ther Adv Neurol Disord; 2018; 11():1756286418803246. PubMed ID: 30305849
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy.
Kizina K; Stolte B; Totzeck A; Bolz S; Fleischer M; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
Front Neurol; 2019; 10():1166. PubMed ID: 31787921
[No Abstract] [Full Text] [Related]
3. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
[TBL] [Abstract][Full Text] [Related]
5. Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience.
Łusakowska A; Wójcik A; Frączek A; Aragon-Gawińska K; Potulska-Chromik A; Baranowski P; Nowak R; Rosiak G; Milczarek K; Konecki D; Gierlak-Wójcicka Z; Burlewicz M; Kostera-Pruszczyk A
Orphanet J Rare Dis; 2023 Aug; 18(1):230. PubMed ID: 37542300
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal Deformity.
Papaliagkas V; Foroglou N; Toulios P; Moschou M; Gavriilaki M; Notas K; Chatzikyriakou E; Zafeiridou G; Arnaoutoglou M; Kimiskidis VK
Case Rep Neurol; 2021; 13(3):710-715. PubMed ID: 34950009
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: Real world data from Hungarian patients.
Szabó L; Gergely A; Jakus R; Fogarasi A; Grosz Z; Molnár MJ; Andor I; Schulcz O; Goschler Á; Medveczky E; Czövek D; Herczegfalvi Á
Eur J Paediatr Neurol; 2020 Jul; 27():37-42. PubMed ID: 32456992
[TBL] [Abstract][Full Text] [Related]
8. Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen.
Carrera-García L; Muchart J; Lazaro JJ; Expósito-Escudero J; Cuadras D; Medina J; Bosch de Basea M; Colomer J; Jimenez-Mallebrera C; Ortez C; Natera-de Benito D; Nascimento A
Eur J Paediatr Neurol; 2021 Mar; 31():92-101. PubMed ID: 33711792
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience.
Milella G; Introna A; D'Errico E; Fraddosio A; Scaglione G; Morea A; Ucci M; Ruggieri M; Mastrapasqua M; Megna M; Puntillo F; Simone IL
Clin Drug Investig; 2021 Sep; 41(9):775-784. PubMed ID: 34389971
[TBL] [Abstract][Full Text] [Related]
10. Cone-beam computed tomography guided nusinersen administrations in adult spinal muscular atrophy patients with challenging access: a single- center experience.
Salapura V; Snoj Z; Leonardis L; Koritnik B; Kostadinova V
Radiol Oncol; 2022 Aug; 56(3):319-325. PubMed ID: 35962954
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy.
Cordts I; Lingor P; Friedrich B; Pernpeintner V; Zimmer C; Deschauer M; Maegerlein C
Ther Adv Neurol Disord; 2020; 13():1756286419887616. PubMed ID: 32010224
[TBL] [Abstract][Full Text] [Related]
12. Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity. Feasibility, safety and radiation exposure considerations.
Spiliopoulos S; Reppas L; Zompola C; Palaiodimou L; Papadopoulou M; Filippiadis D; Palialexis K; Ploussi A; Efstathopoulos E; Tsivgoulis G; Brountzos E
Eur J Neurol; 2020 Jul; 27(7):1343-1349. PubMed ID: 32250518
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.
Veiga-Canuto D; Cifrián-Pérez M; Pitarch-Castellano I; Vázquez-Costa JF; Aparici F
Eur J Neurol; 2021 Feb; 28(2):676-680. PubMed ID: 33051940
[TBL] [Abstract][Full Text] [Related]
14. Nusinersen treatment significantly improves hand grip strength, hand motor function and MRC sum scores in adult patients with spinal muscular atrophy types 3 and 4.
De Wel B; Goosens V; Sobota A; Van Camp E; Geukens E; Van Kerschaver G; Jagut M; Claes K; Claeys KG
J Neurol; 2021 Mar; 268(3):923-935. PubMed ID: 32935160
[TBL] [Abstract][Full Text] [Related]
15. Nusinersen Treatment of Children with Later-Onset Spinal Muscular Atrophy and Scoliosis Is Associated with Improvements or Stabilization of Motor Function.
Dunaway Young S; Montes J; Glanzman AM; Gee R; Day JW; Finkel RS; Darras BT; De Vivo DC; Gambino G; Foster R; Wong J; Garafalo S; Berger Z;
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568304
[TBL] [Abstract][Full Text] [Related]
16. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
[TBL] [Abstract][Full Text] [Related]
17. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
[TBL] [Abstract][Full Text] [Related]
18. Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen.
Jochmann E; Steinbach R; Jochmann T; Chung HY; Rödiger A; Neumann R; Mayer TE; Kirchhof K; Loudovici-Krug D; Smolenski UC; Witte OW; Grosskreutz J
Ther Adv Neurol Disord; 2020; 13():1756286420907803. PubMed ID: 32180828
[TBL] [Abstract][Full Text] [Related]
19. Scoliosis Orthopedic Surgery Combined With Nusinersen Intrathecal Injection Significantly Improved the Outcome of Spinal Muscular Atrophy Patient: A Case Report.
Xu B; Wei C; Hu X; Li W; Huang Z; Que C; Qiu J; Li C; Xiong H
Front Neurol; 2022; 13():869230. PubMed ID: 35547367
[TBL] [Abstract][Full Text] [Related]
20. Nusinersen for spinal muscular atrophy types II and III: a retrospective single-center study in South Korea.
Shin HJ; Na JH; Lee H; Lee YM
World J Pediatr; 2023 May; 19(5):450-459. PubMed ID: 36441395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
